Delivery Order SPE2DB24D1007-SPE2DB25FB5UB
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors valued at $11,830.00. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to complete by September 18, 2025, with performance executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed-price delivery order, valued at $11.83K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99M prime vendor agreement extending through December 2026. The delivery order carries no set-aside designation and requires...
- The Defense Logistics Agency awarded a delivery order valued at $12,604.63 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. The contract, which carries an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication, with performance at the contractor's Conshohocken, Pennsylvania facility. This non-set-aside competitive award was issued on June 27, 2025, with an ultimate completion date of July 21, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injection delivery systems. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 1, 2025. The contract represents a fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $35,490 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body auto-injector units. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of July 22, 2025, to be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FB5UBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectable medication. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 20, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills medical supply orders for military and veteran healthcare systems through competitive delivery orders. As a prime contractor under the DLA's comprehensive pharmaceutical support vehicle, the company supplies a broad range of pharmaceuticals, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare customers. This particular delivery order for SKYRIZI, a dermatological biologic medication, exemplifies the company's role in providing specialized pharmaceutical products to federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 9/26/25 |